"It's the Economy, Stupid": Strategies for Improved Cost Containment in Cancer Treatment

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)


The advent of numerous novel antitumor compounds has improved the prognosis of many cancer patients but has also substantially increased the costs of cancer care and put more pressure on health-care budgets. This situation increasingly raises questions such as the extent to which these drugs offer value sufficient to justify their cost and how to accommodate the increasing costs of cancer care. Here I look at the various aspects that affect cancer care economics and offer potential solutions.
Original languageUndefined/Unknown
Pages (from-to)365-367
Number of pages3
JournalClinical Pharmacology & Therapeutics
Issue number4
Publication statusPublished - 2014

Cite this